Researchers used follow-up data from the European Randomized Study of Screening for Prostate Cancer (ERSPC) to predict how PSA screening would affect prostate cancer diagnoses, deaths, treatments and men's ... Overdiagnosis of prostate cancer was the
Colon cancer: annual fecal occult blood testing, flexible sigmoidoscopy or screening colonoscopy every 48 or 120 months depending on risk. ... Newman said. Prostate cancer: coverage for annual digital rectal exam (minus a 20% copayment) and
years, because the harms of prostate cancer screening outweigh the benefits for these patients. ... ACP developed this guidance statement for clinicians by assessing current prostate cancer screening guidelines developed by other organizations.
Researchers at the Mayo Clinic in Rochester, Minn., looked at 2,219 patients who underwent radical prostatectomy between 1994 and 2004 for localized prostate cancer. ... A benefit to an upfront, aggressive surgical approach to localized prostate cancer
how some common phrases may sound through the filter of a cancer diagnosis. ... The Decision Laboratory. This nonprofit group develops and evaluates decision support interventions for specific conditions, including breast cancer and prostate cancer.
https://acpinternist.org/weekly/archives/2010/02/09/4.htm. Internists should follow up with prostate cancer patients receiving ADT.
https://acpinternist.org/weekly/archives/2010/08/03/5.htm. Low-risk, low-PSA prostate cancer receiving aggressive interventions. An insurance company's effort to encourage physicians to reduce use of
The most commonly reported problems associated with an enlarged prostate are increased urinary frequency and nocturia, he noted. ... Middle-aged men may also approach their internists about the possibility of prostate-specific antigen (PSA) testing to
https://acpinternist.org/weekly/archives/2010/08/31/4.htm. Annual PSA follow-ups not needed in low-risk casesComorbid illnesses still more likely to kill prostate cancer survivors.
A second safety net aims to prevent lung cancer by focusing on incidental lung nodules. ... New safety nets that the team is working on include medication safety, prostate cancer, cervical cancer, breast cancer, and diagnostic errors, said Dr.